126 related articles for article (PubMed ID: 38907991)
1. Enhanced Prostate-specific Membrane Antigen Targeting by Precision Control of DNA Scaffolded Nanoparticle Ligand Presentation.
Jana D; Han Z; Huang X; Wadhwa A; Raveendran A; Ebeid K; Meher N; Flavell RR; Desai T
ACS Nano; 2024 Jun; ():. PubMed ID: 38907991
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen.
Meher N; Seo K; Wang S; Bidkar AP; Fogarty M; Dhrona S; Huang X; Tang R; Blaha C; Evans MJ; Raleigh DR; Jun YW; VanBrocklin HF; Desai TA; Wilson DM; Ozawa T; Flavell RR
ACS Appl Mater Interfaces; 2021 Nov; 13(46):54739-54752. PubMed ID: 34752058
[TBL] [Abstract][Full Text] [Related]
3. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
[TBL] [Abstract][Full Text] [Related]
4. Design of Chitosan-Coated, Quercetin-Loaded PLGA Nanoparticles for Enhanced PSMA-Specific Activity on LnCap Prostate Cancer Cells.
Essa D; Kondiah PPD; Kumar P; Choonara YE
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189819
[TBL] [Abstract][Full Text] [Related]
5. Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers.
Meher N; Ashley GW; Bidkar AP; Dhrona S; Fong C; Fontaine SD; Beckford Vera DR; Wilson DM; Seo Y; Santi DV; VanBrocklin HF; Flavell RR
ACS Appl Mater Interfaces; 2022 Nov; 14(45):50569-50582. PubMed ID: 36318757
[TBL] [Abstract][Full Text] [Related]
6. Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy.
Lee S; Lee Y; Kim H; Lee DY; Jon S
Biomacromolecules; 2018 Jun; 19(6):2270-2277. PubMed ID: 29712433
[TBL] [Abstract][Full Text] [Related]
7. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
8. Fine tuning neuronal targeting of nanoparticles by adjusting the ligand grafting density and combining PEG spacers of different length.
Pereira Gomes C; Leiro V; Ferreira Lopes CD; Spencer AP; Pêgo AP
Acta Biomater; 2018 Sep; 78():247-259. PubMed ID: 30092376
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Study of the Interaction of Multivalent Ligand-Modified Nanoparticles with Breast Cancer Cells with Tunable Receptor Density.
Wang J; Min J; Eghtesadi SA; Kane RS; Chilkoti A
ACS Nano; 2020 Jan; 14(1):372-383. PubMed ID: 31899613
[TBL] [Abstract][Full Text] [Related]
10. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.
Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S
Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708
[TBL] [Abstract][Full Text] [Related]
11. Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles.
Wang M; Miller AD; Thanou M
J Drug Target; 2013 Aug; 21(7):684-92. PubMed ID: 23773028
[TBL] [Abstract][Full Text] [Related]
12. A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo.
Lee JB; Zhang K; Tam YY; Quick J; Tam YK; Lin PJ; Chen S; Liu Y; Nair JK; Zlatev I; Rajeev KG; Manoharan M; Rennie PS; Cullis PR
Mol Ther Nucleic Acids; 2016; 5(8):e348. PubMed ID: 28131285
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?
Luo D; Wang X; Zeng S; Ramamurthy G; Burda C; Basilion JP
Chem Sci; 2019 Sep; 10(35):8119-8128. PubMed ID: 31588336
[TBL] [Abstract][Full Text] [Related]
14. Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel.
Saniee F; Shabani Ravari N; Goodarzi N; Amini M; Atyabi F; Saeedian Moghadam E; Dinarvand R
Pharm Dev Technol; 2021 Apr; 26(4):381-389. PubMed ID: 33538232
[TBL] [Abstract][Full Text] [Related]
15. Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging.
Jin H; Lovell JF; Chen J; Ng K; Cao W; Ding L; Zhang Z; Zheng G
Cancer Nanotechnol; 2010; 1(1-6):71-78. PubMed ID: 26316895
[TBL] [Abstract][Full Text] [Related]
16. Cell surface biotinylation to identify the receptors involved in nanoparticle uptake into endothelial cells.
Aliyandi A; Reker-Smit C; Zuhorn IS; Salvati A
Acta Biomater; 2023 Jan; 155():507-520. PubMed ID: 36371002
[TBL] [Abstract][Full Text] [Related]
17. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
18. Multivalent effect of peptide functionalized polymeric nanoparticles towards selective prostate cancer targeting.
Murar M; Pujals S; Albertazzi L
Nanoscale Adv; 2023 Feb; 5(5):1378-1385. PubMed ID: 36866255
[TBL] [Abstract][Full Text] [Related]
19. Design and investigation of targeting agent orientation and density on nanoparticles for enhancing cellular uptake efficiency.
Fei W; Wang X; Guo J; Wang C
J Mater Chem B; 2023 Aug; 11(34):8228-8240. PubMed ID: 37565424
[TBL] [Abstract][Full Text] [Related]
20. Ligand Density Controls C-Type Lectin-Like Molecule-1 Receptor-Specific Uptake of Polymer Nanoparticles.
Ackun-Farmmer MA; Alatise KL; Cross G; Benoit DSW
Adv Biosyst; 2020 Nov; 4(11):e2000172. PubMed ID: 33073549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
